Elevance Health Inc.

447.10-3.73-0.83%Vol 806.19K1Y Perf -2.60%
Sep 22nd, 2023 16:00 DELAYED
BID438.76 ASK453.19
Open448.23 Previous Close450.83
Pre-Market- After-Market447.09
 - -  -0.01 0.00%
Target Price
568.44 
Analyst Rating
Strong Buy 1.22
Potential %
27.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     46.85
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     39.44
Price Range Ratio 52W %
25.52 
Earnings Rating
Market Cap105.36B 
Earnings Date
18th Oct 2023
Alpha0.01 Standard Deviation0.08
Beta0.84 

Today's Price Range

446.16451.57

52W Range

412.00549.52

5 Year PE Ratio Range

9.3026.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
1.17%
1 Month
-2.77%
3 Months
-0.73%
6 Months
0.18%
1 Year
-2.60%
3 Years
85.70%
5 Years
71.59%
10 Years
509.36%

TickerPriceChg.Chg.%
ELV447.10-3.7300-0.83
AAPL174.790.86000.49
GOOG131.25-0.1100-0.08
MSFT317.01-2.5200-0.79
XOM114.940.18000.16
WFC41.23-1.0900-2.58
JNJ160.50-1.1600-0.72
FB196.640.99000.51
GE111.25-1.7400-1.54
JPM145.73-1.4100-0.96
ProfitabilityValueIndustryS&P 500US Markets
-
5.80
-
4.90
4.34
RevenueValueIndustryS&P 500US Markets
116.67B
488.50
-
-
DividendsValueIndustryS&P 500US Markets
1.09
5.12
13.94
11.77
Payout ratio-
Earnings HistoryEstimateReportedSurprise %
Q02 20238.829.042.49
Q01 20239.269.462.16
Q04 20225.205.230.58
Q03 20227.107.536.06
Q02 20227.728.044.15
Q01 20227.818.255.63
Q04 20215.115.140.59
Q03 20216.356.796.93
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date18th Oct 2023
Estimated EPS Next Report8.45
Estimates Count12
EPS Growth Next 5 Years %-
Volume Overview
Volume806.19K
Shares Outstanding235.65K
Shares Float235.23M
Trades Count21.34K
Dollar Volume361.47M
Avg. Volume1.10M
Avg. Weekly Volume1.16M
Avg. Monthly Volume995.86K
Avg. Quarterly Volume1.15M

Elevance Health Inc. (NYSE: ELV) stock closed at 447.1 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 806.19K shares and market capitalization of 105.36B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 98200 people. Elevance Health Inc. CEO is Gail Koziara Boudreaux.

The one-year performance of Elevance Health Inc. stock is -2.6%, while year-to-date (YTD) performance is -12.84%. ELV stock has a five-year performance of 71.59%. Its 52-week range is between 412 and 549.52, which gives ELV stock a 52-week price range ratio of 25.52%

Elevance Health Inc. currently has a PE ratio of 18.60, a price-to-book (PB) ratio of 3.16, a price-to-sale (PS) ratio of 0.96, a price to cashflow ratio of 10.00, a PEG ratio of -, a ROA of 6.18%, a ROC of -% and a ROE of 17.32%. The company’s profit margin is 4.34%, its EBITDA margin is -%, and its revenue ttm is $116.67 Billion , which makes it $488.49 revenue per share.

Of the last four earnings reports from Elevance Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $8.45 for the next earnings report. Elevance Health Inc.’s next earnings report date is 18th Oct 2023.

The consensus rating of Wall Street analysts for Elevance Health Inc. is Strong Buy (1.22), with a target price of $568.44, which is +27.14% compared to the current price. The earnings rating for Elevance Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elevance Health Inc. has a dividend yield of 1.09% with a dividend per share of $5.12 and a payout ratio of -%.

Elevance Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 42.30, ATR14 : 8.48, CCI20 : 6.70, Chaikin Money Flow : -0.09, MACD : -3.39, Money Flow Index : 49.45, ROC : 0.25, RSI : 47.06, STOCH (14,3) : 60.28, STOCH RSI : 0.74, UO : 52.15, Williams %R : -39.72), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elevance Health Inc. in the last 12-months were: Charles Morgan Kendrick (Sold 2 314 shares of value $1 069 577 ), Dixon Robert L JR (Sold 310 shares of value $147 780 ), Gloria M. McCarthy (Sold 15 098 shares of value $6 714 978 ), Kendrick Charles (Sold 2 314 shares of value $1 069 577 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
13 (81.25 %)
13 (81.25 %)
12 (85.71 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
2 (14.29 %)
Hold
1 (6.25 %)
1 (6.25 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.22
Strong Buy
1.22
Strong Buy
1.11

Elevance Health Inc.

Anthem remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.

CEO: Gail Koziara Boudreaux

Telephone: +1 800 331-1476

Address: 220 Virginia Avenue, Indianapolis 46204, IN, US

Number of employees: 98 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

Bearish Bullish

52%48%

 

News

Stocktwits